Clinical trial NCT01024491 - References

Premature Ejaculation — Efficacy and Safety of Paroxetine Daily Doses of 15 mg and 20 mg in the Treatment of Premature Ejaculation

Citation(s)

•   Althof S, Rosen R, Symonds T, Mundayat R, May K, Abraham L
  Development and validation of a new questionnaire to assess sexual satisfaction, control, and distress associated with premature ejaculation. J Sex Med. 2006 May;3(3):465-75.
•   Althof SE
  Prevalence, characteristics and implications of premature ejaculation/rapid ejaculation. J Urol. 2006 Mar;175(3 Pt 1):842-8. Review.
•   American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed, Text Revision
  Washington, DC, American Psychiatric Association, 2000.
•   Jannini EA, Lenzi A
  Epidemiology of premature ejaculation. Curr Opin Urol. 2005 Nov;15(6):399-403. Review.
•   McMahon C
  Premature ejaculation: past, present, and future perspectives. J Sex Med. 2005 May;2 Suppl 2:94-5. Review.
•   Rosen RC, Cappelleri JC, Gendrano N 3rd
  The International Index of Erectile Function (IIEF): a state-of-the-science review. Int J Impot Res. 2002 Aug;14(4):226-44. Review.
•   Waldinger MD, Hengeveld MW, Zwinderman AH
  Ejaculation-retarding properties of paroxetine in patients with primary premature ejaculation: a double-blind, randomized, dose-response study. Br J Urol. 1997 Apr;79(4):592-5.
•   Waldinger MD, Zwinderman AH, Olivier B
  Antidepressants and ejaculation: a double-blind, randomized, placebo-controlled, fixed-dose study with paroxetine, sertraline, and nefazodone. J Clin Psychopharmacol. 2001 Jun;21(3):293-7.
•   Waldinger MD
  Towards evidence-based drug treatment research on premature ejaculation: a critical evaluation of methodology. Int J Impot Res. 2003 Oct;15(5):309-13. Review.

A Parallel Randomized Double Blind Placebo Controlled Clinical Trial to Study the Efficacy and Safety of Paroxetine Daily Doses of 15 mg and 20 mg in the Treatment of Premature Ejaculation

Details for clinical trial NCT01024491